BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study
- 1 February 1998
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 155 (1) , 68-75
- https://doi.org/10.1016/s0022-510x(97)00277-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomasCancer Genetics and Cytogenetics, 1996
- The p53 gene and its role in human brain tumorsGlia, 1995
- Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl‐2 and p53 proteinsNeuropathology and Applied Neurobiology, 1995
- Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damageBioEssays, 1995
- Inactivation of Bcl-2 by phosphorylation.Proceedings of the National Academy of Sciences, 1995
- Biochemical properties and biological effects of p53Current Opinion in Genetics & Development, 1995
- The retinoblastoma gene is involved in malignant progression of astrocytomasAnnals of Neurology, 1994
- p53 In tumour pathology: Can we trust immunohistochemistry?—revisited!The Journal of Pathology, 1994
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993